Lifeboat Foundation

Engineers have created a tiny device that can rapidly detect harmful bacteria in blood, allowing health care professionals to pinpoint the cause of potentially deadly infections and fight them with drugs.

The Rutgers coauthored study, led by researchers at Rochester Institute of Technology, is published in the journal ACS Applied Materials & Interfaces.

“The rapid identification of drug-resistant bacteria allows health care providers to prescribe the right drugs, boosting the chances of survival,” said coauthor Ruo-Qian (Roger) Wang, an assistant professor in the Department of Civil and Environmental Engineering in the School of Engineering at Rutgers University-New Brunswick.

Coronavirus has claimed at least 10,447 lives with a total of 254,701 confirmed cases worldwide. A total of 89,071 people have recovered from the virus. The outbreak has led to panic and pandemonium. As we reported yesterday, there are only three major types of treatments: antiviral drug, antibody solution (including blood plasma) and vaccine.

Even though the need to develop new vaccines seems to be getting a lot of headlines, vaccine, however, does not provide the immediate relief for people who are already infected with the virus. In addition, experts are saying that it may take between 12 to 24 months before the vaccine becomes available. Some are going as far as saying it could be 2022 before we see a COVID-19 vaccine.

In the meantime, more companies are coming out with existing antiviral and experimental drugs that have proven to show promising results in treating COVID-19 patients. While there are no FDA-approved therapeutics or drugs to treat, cure or prevent COVID-19, there are several FDA-approved treatments that may help ease the symptoms from a supportive care perspective.

Everywhere from business to medicine to the climate, forecasting the future is a complex and absolutely critical job. So how do you do it—and what comes next?

SHANGHAI (Reuters) — Researchers at one of China’s top universities have designed a robot they say could help save lives on the frontline during the coronavirus outbreak.

The machine consists of a robotic arm on wheels that can perform ultrasounds, take mouth swabs and listen to sounds made by a patient’s organs, usually done with a stethoscope.

Such tasks are normally carried out by doctors in person. But with this robot, which is fitted with cameras, medical personnel do not need to be in the same room as the patient, and could even be in a different city.

Medical robotics expert Guang-Zhong Yang calls for a global effort to develop new types of robots for fighting infectious diseases.

When I reached Professor Guang-Zhong Yang on the phone last week, he was cooped up in a hotel room in Shanghai, where he had self-isolated after returning from a trip abroad. I wanted to hear from Yang, a widely respected figure in the robotics community, about the role that robots are playing in fighting the coronavirus pandemic. He’d been monitoring the situation from his room over the previous week, and during that time his only visitors were a hotel employee, who took his temperature twice a day, and a small wheeled robot, which delivered his meals autonomously.

An IEEE Fellow and founding editor of the journal Science Robotics, Yang is the former director and co-founder of the Hamlyn Centre for Robotic Surgery at Imperial College London. More recently, he became the founding dean of the Institute of Medical Robotics at Shanghai Jiao Tong University, often called the MIT of China. Yang wants to build the new institute into a robotics powerhouse, recruiting 500 faculty members and graduate students over the next three years to explore areas like surgical and rehabilitation robots, image-guided systems, and precision mechatronics.

Continue reading “Coronavirus Pandemic: A Call to Action for the Robotics Community” »

#Interesting opinion from a #Futurist

Why do the young survive, and older individuals fall ill?

Likely because our immune systems degrade as we age. It’s the same reason that humans see increased cancer rates as we age— as we grow older, our immune systems, which normally find and destroy cancers in our bodies, become overwhelmed, exhausted, depleted.

Continue reading “Augmenting Your Immunity: Fighting COVID-19” »

https://youtube.com/watch?v=6hs_sNGIUls

As the COVID-19 pandemic spreads, robots, drones, and AI are helping healthcare organizations respond to worker shortages and the risk of infection.

DARPA, the Defense Advanced Research Projects Agency that’s responsible for developing emerging technologies for the U.S. military, is building a new high-tech spacecraft — and it’s armed. In an age of Space Force and burgeoning threats like hunter-killer satellites, this might not sound too surprising. But you’re misunderstanding. DARPA’s new spacecraft, currently “in the thick of it” when it comes to development, is armed. As in, it has arms. Like the ones you use for grabbing things.

Armed robots aren’t new. Mechanical robot arms are increasingly widespread here on Earth. Robot arms have been used to carry out complex surgery and flip burgers. Attached to undersea exploration vehicles, they’ve been used to probe submerged wrecks. They’ve been used to open doors, defuse bombs, and decommission nuclear power plants. They’re pretty darn versatile. But space is another matter entirely.

A Covid-19 test can deliver results in less than an hour has been approved under an FDA emergency authorization, marking the first test that clinicians can use at the bedside.

Testing shortages have been an ongoing challenge in the U.S. response to curb the pandemic. The White House has promised testing will ramp up as more private companies come on board.

Public health and clinical labs have run more than 195,000 tests to date, but that doesn’t include hospital laboratories running their own test, Brett Giroir, assistant secretary for health at the U.S. Department of Health and Human Services, said during a White House briefing Saturday.